QIAGEN N.V.
QGEN
$32.70
-$1.00-2.97%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.79% | 5.65% | 5.32% | 5.15% | 3.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.79% | 5.65% | 5.32% | 5.15% | 3.31% |
| Cost of Revenue | 7.45% | 7.87% | -56.61% | -56.63% | 1.45% |
| Gross Profit | 3.46% | 4.55% | 63.81% | 62.85% | 4.26% |
| SG&A Expenses | 4.35% | 3.42% | 0.51% | 0.18% | -1.17% |
| Depreciation & Amortization | -1.65% | -7.19% | -14.24% | -16.74% | -13.94% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.35% | 4.06% | -30.79% | -31.11% | -1.12% |
| Operating Income | 3.22% | 10.43% | 363.14% | 391.20% | 18.36% |
| Income Before Tax | 229.86% | 304.69% | 344.03% | 400.98% | -67.30% |
| Income Tax Expenses | 21.57% | 74.10% | 378.27% | 363.95% | -48.21% |
| Earnings from Continuing Operations | 329.31% | 408.28% | 336.20% | 413.63% | -72.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 329.31% | 408.28% | 336.20% | 413.63% | -72.20% |
| EBIT | 3.22% | 10.43% | 363.14% | 391.20% | 18.36% |
| EBITDA | 2.85% | 5.42% | 167.75% | 172.57% | 10.19% |
| EPS Basic | 335.83% | 414.70% | 340.74% | 419.35% | -72.74% |
| Normalized Basic EPS | 2.71% | 10.31% | 312.19% | 335.19% | 17.94% |
| EPS Diluted | 348.51% | 423.00% | 346.81% | 428.79% | -73.46% |
| Normalized Diluted EPS | 2.52% | 10.18% | 315.11% | 339.03% | 18.39% |
| Average Basic Shares Outstanding | 0.21% | 0.35% | 0.32% | 0.34% | 0.31% |
| Average Diluted Shares Outstanding | 0.39% | 0.41% | 0.38% | 0.35% | -0.10% |
| Dividend Per Share | -100.00% | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |